Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study.

Abstract

The term 'aerobic vaginitis' defines a 'new' vaginal pathology that is neither classifiable as specific vaginitis nor as bacterial vaginosis. We studied a sample of 30 women with a clinical and microbiological diagnosis of aerobic vaginitis and compared the efficacy and tolerability of kanamycin and meclocycline, two products commercially available in Italy in the form of vaginal pessaries. In chronological order of enrollment, the patients were alternately treated with kanamycin or meclocycline; the dose of administration in both groups was of one pessary per day for 6 days. The evaluation of the therapeutic efficacy was carried out both at the first check-up (7th-8th day) and at a second check-up (13th-16th day). At the first follow-up carried out immediately at the end of therapy, the percentage of normalisation of clinical signs and symptoms was increased independently of the type of treatment in the case of moderate grade aerobic vaginitis, while kanamycin was produced a better effect in the group with severe aerobic vaginitis. Furthermore, at the second follow-up, a direct correlation with recovery of vaginal homeostasis was demonstrated by the normalisation of the vaginal pH and by the presence of lactobacilli, only in kanamycin treated group. In conclusion, our results showed the validity of the treatment with kanamycin intravaginally in this recently recognised disease.

• Authors: G Tempera, G Bonfiglio, E Cammarata, S Corsello, A Cianci
• Journal: International journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 24 Issue 1 Pg. 85-8 (Jul 2004) ISSN: 0924-8579 [Print] Netherlands
• PMID: 15225868 (Publication Type: Clinical Trial, Journal Article, Validation Study)

Chemical References

• Kanamycin

Topics

• Administration, Topical
• Female
• Humans
• Kanamycin (administration & dosage, therapeutic use)
• Pilot Projects
• Vaginitis (drug therapy)